A world-class cancer centre is to be built at University College London, to join a growing list of similar centres nationwide.
Run by Cancer Research UK, the new UCL centre will research the causes of the disease and why they develop, with the aim of using this knowledge to develop new drugs and therapies.
In particular, the UCL Centre will focus on the biology and treatment of blood cancers, sarcomas, brain cancer, ovarian cancer, head and neck cancer and lung cancer.
Many of these cancers - particularly lung and brain - are hard to treat successfully and have poor long term survival rates compared to other common cancers.
It joins other centres of excellence funded by the charity at Newcastle, Birmingham, Liverpool, Belfast, Southampton and Cardiff.
Professor David Linch, director of the new UCL Cancer Research UK Centre, said: ‘By joining the network of Cancer Research UK Centres across the UK we will be able to build on our world class research bringing benefits to patients, doctors and scientists.
‘This new centre will strengthen the work we already do in taking new treatments straight from the laboratory to the clinic, bringing real benefits to people with cancer. Our vision is to supply high quality care to all patients by creating research platforms that enable the development of new and innovative therapies.’